Literature DB >> 16293626

DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters, via p53 C-terminal lysines.

Valentina Basile1, Roberto Mantovani, Carol Imbriano.   

Abstract

Repression of G(2)/M promoters after DNA damage is an active mechanism that requires the p53 tumor suppressor. We have recently found that histone deacetylase 4 (HDAC4) is recruited on NF-Y-dependent repressed promoters. In this report, we describe the relationship between p53 and HDAC4 recruitment following DNA damage using immunofluorescence, chromatin immunoprecipitation, and transfection experiments. HDAC4 shuttles from the cytoplasm into the nucleus, following DNA damage, independently of the activation of p53 and becomes associated with promoters through a p53-dependent mechanism. The C-terminal lysines of p53, which are acetylated and methylated, are required for HDAC4 recruitment and transcriptional repression. Trichostatin treatment, but not HDAC4 functional inactivation, relieves the adriamycin-mediated repression of G(2)/M promoters. Our results indicate that HDAC4 is a component of the DNA damage response and that post-translational modifications of p53 are important for repression of G(2)/M genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293626     DOI: 10.1074/jbc.M507712200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Deacetylation by SIRT1 Reprograms Inflammation and Cancer.

Authors:  Tie Fu Liu; Charles E McCall
Journal:  Genes Cancer       Date:  2013-03

2.  Nuclear transcription factor Y and its roles in cellular processes related to human disease.

Authors:  Luong Linh Ly; Hideki Yoshida; Masamitsu Yamaguchi
Journal:  Am J Cancer Res       Date:  2013-08-14       Impact factor: 6.166

Review 3.  NF-Y (CBF) regulation in specific cell types and mouse models.

Authors:  Sankar N Maity
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2016-11-02       Impact factor: 4.490

4.  Higher anti-tumour efficacy of platinum(IV) complex LA-12 is associated with its ability to bypass M-phase entry block induced in oxaliplatin-treated human colon cancer cells.

Authors:  O Vondálová Blanářová; I Jelínková; A Hyršlová Vaculová; P Sova; J Hofmanová; A Kozubík
Journal:  Cell Prolif       Date:  2013-09-30       Impact factor: 6.831

Review 5.  Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.

Authors:  Prithviraj Bose; Yun Dai; Steven Grant
Journal:  Pharmacol Ther       Date:  2014-04-24       Impact factor: 12.310

6.  Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.

Authors:  Raafat A El-Awady; Fatema Hersi; Hala Al-Tunaiji; Ekram M Saleh; Abdel-Hady A Abdel-Wahab; Amer Al Homssi; Mousa Suhail; Ahmed El-Serafi; Taleb Al-Tel
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 7.  Class IIA HDACs in the regulation of neurodegeneration.

Authors:  Nazanin Majdzadeh; Brad E Morrison; Santosh R D'Mello
Journal:  Front Biosci       Date:  2008-01-01

8.  A role for the histone deacetylase HDAC4 in the life-cycle of HIV-1-based vectors.

Authors:  Johanna A Smith; Jennifer Yeung; Gary D Kao; René Daniel
Journal:  Virol J       Date:  2010-09-16       Impact factor: 4.099

Review 9.  Protein methylation: a new mechanism of p53 tumor suppressor regulation.

Authors:  A Scoumanne; X Chen
Journal:  Histol Histopathol       Date:  2008-09       Impact factor: 2.303

10.  Phospho-ΔNp63α/microRNA feedback regulation in squamous carcinoma cells upon cisplatin exposure.

Authors:  Yiping Huang; Dafna Kesselman; Darya Kizub; Rafael Guerrero-Preston; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2013-01-23       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.